Publication | Closed Access

Results of a phase III prospective, randomised trial, comparing mitoxantrone and vinorelbine (MV) in combination with standard FAC/FEC in front-line therapy of metastatic breast cancer

Metastatic Breast CancerBreast OncologyMedicinePharmacologyPhase Iii ProspectiveBreast CancerPharmacotherapyStandard Fac/fecCancer TreatmentOncologyRadiation OncologyRadiologyHealth Sciences